NCT03266874Active, not recruiting
G7 BiSpherical Acetabular Shell PMCF Study
Prospective Multicenter Observational Evaluation of the Use of the G7 BiSpherical Acetabular Shell
Source: ClinicalTrials.gov · Last updated 25 Jun 2025
Brief summary (registry, in English)
The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available G7 BiSpherical Acetabular Shell.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 160 (estimated)
- First submitted
- 24 Aug 2017
- Start date
- 10 Dec 2017
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Zimmer Biomet
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT03266874
What you commit to
- Study type: Observational
- Planned participants: 160
- From 10 Dec 2017 to the primary completion date, 31 Dec 2029
- 5 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient institutionalized or known drug abuser or alcoholic or anyone who cannot understand what is required of them.
- Bone or musculature compromised by disease, infection, or prior implantation that cannot provide adequate support or fixation for the prosthesis.
Other illness
- Infection, sepsis, osteomyelitis.
- Relative exclusion criteria include:
- Uncooperative patient or patient with neurologic disorders who is incapable of following directions.
- Metabolic disorders which may impair bone formation.
- Distant foci of infections which may spread to the implant site.
- Vascular insufficiency, muscular atrophy or neuromuscular disease.
- Patient presenting any condition that would, in the judgment of the Investigator, place the patient at undue risk or interfere with the study.
Other
- Absolute exclusion criteria include:
- Osteoporosis.
- Osteomalacia.
- Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram.
- Patient unwilling or unable to give consent, or to comply with the follow-up program.
- Patient known to be pregnant or breastfeeding.
- Patient belonging to a vulnerable population.
Who the study is looking for
- Patient capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study.
- Patient aged of 18 years or more whose skeleton reached bone maturity.
- Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
- Rheumatoid arthritis.
- Correction of functional deformity.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
- Revision procedures where other treatment or devices have failed.
- The Biomet G7 Freedom Constrained Liner is indicated for use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability, and for whom all other options to con-strained acetabular components have been considered.
Age in the registry: 18 years to - · Sex: All
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Orthoprax AG Coordinator of this site? Confirm its status | Bern | Switzerland | Unknown status |
| Herzogin Elisabeth Hospital Coordinator of this site? Confirm its status | Braunschweig | Germany | Unknown status |
| Orthopädische Chirurgie Müchen OCM Coordinator of this site? Confirm its status | Munich | Germany | Unknown status |
| Cabinet du Dr. Miazzolo Coordinator of this site? Confirm its status | Perpignan | France | Unknown status |
| Reinier de Graaf Groep Coordinator of this site? Confirm its status | Delft | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.